Together, we believe our wealth of experience and scientific expertise will allow us to deliver on the promise of our novel Ta:RNA™ platform, helping to transform outcomes for cancer patients everywhere.
Peter Braun
Chief Executive Officer
Christoph Rentsch
CFO, Member of the Board
Dr. Veronica Hersberger
Chief Medical Officer
Dr. Esteban Pombo-Villar, PhD
Chief Technology Officer
Dr. Maya Zigler, PhD
Head of Research
Dr. Frank Hennecke
Head of CMC
Marc Thommen
Head of Technical Development
Catherine Ammann
Chief People Officer
Bruno Heynen
General Counsel
Dr. Kuno Sommer, PhD
Chairman of the Board
Dr. Peter Kash, EdD, MBA
Vice Chairman, Co-founder
Prof. Alex Levitzki, PhD
Board Member, Co- Founder/Co-Inventor
Paolo Fundarò
Board Member
Christoph Rentsch
Executive Director, Board Member